evaluate long-term effects of losartan versus atenolol on cardiovascular morbidity and mortality. The Valsartan Heart Failure Trial (Val-HeFT), a multinational trial involving more than 4000 ...

Results of recent key studies such as Losartan Intervention For Endpoint Reduction in Hypertension (LIFE), Valsartan in Heart Failure Trial (Val-HeFT), Candesartan in Heart Failure Assessment of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving ...

Sacubitril/valsartan reduced cardiomyopathy risk by 77% in cancer patients on anthracycline chemotherapy, as shown in the SARAH trial. The trial involved 114 adults, primarily women with breast ...

Get detailed information on Valsartan, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

In pediatric patients with heart failure related to systemic LVSD, sacubitril/valsartan vs enalapril are equally efficacious and safe. Sacubitril/valsartan is equally efficacious and safe vs enalapril ...

Background: Valsartan has previously been shown to attenuate cardiac remodeling among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM), a condition characterized, in part, by ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

The following is a summary of “Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF,” published in the October 2024 issue of ...

The following is a summary of “Impact of Race on Sacubitril/Valsartan use of HF,” published in the October 2024 issue of Cardiology by Lu et al. There is limited understanding of how self-reported ...